Pulmonx (LUNG) Total Liabilities (2019 - 2025)

Pulmonx (LUNG) has 7 years of Total Liabilities data on file, last reported at $75.2 million in Q4 2025.

• Total Liabilities for Q4 2025 came in at $75.2 million, down 2.42% year-over-year; the trailing twelve-month figure through Dec 2025 was $75.2 million (down 2.42% YoY), and the FY2025 annual result was $75.2 million, down 2.42% from the prior year.
• Total Liabilities fell to $75.2 million in Q4 2025 per LUNG's latest filing, from $78.2 million in the prior quarter.
• Over five years, Total Liabilities peaked at $78.2 million in Q3 2025 and troughed at $38.7 million in Q3 2022.
• A 5-year average of $57.0 million and a median of $58.2 million in 2023 frame the typical range for Total Liabilities.
• The sharpest annual moves came in 2021 and 2023: Total Liabilities plunged 80.53% in 2021, then jumped 53.08% in 2023.
• A 5-year view of Total Liabilities shows it stood at $41.9 million in 2021, then slipped by 5.4% to $39.7 million in 2022, then jumped by 49.91% to $59.5 million in 2023, then rose by 29.55% to $77.0 million in 2024, then declined by 2.42% to $75.2 million in 2025.
• Business Quant data shows LUNG's Total Liabilities at $75.2 million in Q4 2025, $78.2 million in Q3 2025, and $78.1 million in Q2 2025.